NAD+ and Cellular Research: Why Independent Labs Are Prioritizing Coenzyme Studies in 2026

Nicotinamide adenine dinucleotide - widely referred to as NAD+ - is a coenzyme present in every living cell, playing a central role in cellular energy metabolism and DNA repair pathways. Over the past decade, independent research facilities have increasingly focused on NAD+ as a key variable in cellular aging research.

Unlike many research compounds that emerged recently, NAD+ has decades of biochemical literature behind it. What has changed is the growing interest in how supplemental NAD+ research compounds interact with cellular decline pathways - particularly within longevity and metabolic research settings.

Preclinical and cellular research has examined NAD+ across several mechanisms:

• Mitochondrial function and cellular energy production pathways
• Sirtuin activation research (proteins associated with cellular aging regulation)
• DNA repair pathway observation
• NAD+ decline patterns observed in aging cellular models
• Interaction with PARP enzyme pathways involved in DNA damage response

Research published in journals including Cell Metabolism and Nature Communications has examined NAD+ decline as a hallmark of cellular aging, driving significant interest in research protocols studying NAD+ replenishment mechanisms.

It is important to note that NAD+ research compounds remain intended strictly for laboratory research. They have not been approved by the FDA for human therapeutic use and are intended only for use by qualified research professionals.

The growing research interest in NAD+ stems from several converging factors:

Cellular energy pathway relevance: NAD+ is directly involved in mitochondrial function, making it central to metabolic and energy research models.

Aging biomarker research: NAD+ levels have been observed to decline with age in cellular studies, making it a frequently referenced variable in longevity research protocols.

Sirtuin pathway interest: Continued research interest in sirtuin proteins - often discussed alongside caloric restriction and longevity research - has kept NAD+ central to related study designs.

Established literature base: Unlike newer research peptides, NAD+ has an extensive existing body of biochemical research, providing researchers with a stronger foundational reference point.

NAD+ stability is particularly sensitive to handling and storage conditions, making sourcing verification critical for research reproducibility:

• ✓Minimum 99% purity confirmed by HPLC testing
• ✓Third-party Certificate of Analysis (CoA) available per batch
• ✓US-based synthesis and manufacturing
• ✓Proper lyophilization and cold-chain handling (NAD+ degrades rapidly without proper storage)
• ✓Clear research-use-only documentation

NAD+ is notably unstable compared to many other research compounds - improper storage or handling during shipping can significantly degrade compound integrity before it ever reaches a research setting. This makes cold-chain verification especially important for this specific compound class.

TheraTide USA manufactures and supplies research-grade NAD+ from its US-based facility, with strict cold-chain handling protocols given the compound's sensitivity. All batches are third-party tested and accompanied by a Certificate of Analysis.

For research teams studying cellular aging and metabolic pathways, consistent, well-documented NAD+ sourcing removes a significant variable from protocol design. TheraTide currently supplies independent research groups across multiple US-based laboratory facilities.

Products are provided strictly for laboratory research use by qualified professionals. Not for human consumption.